コンテンツへスキップ
Merck

Disrupting proton dynamics and energy metabolism for cancer therapy.

Nature reviews. Cancer (2013-08-24)
Scott K Parks, Johanna Chiche, Jacques Pouysségur
要旨

Intense interest in the 'Warburg effect' has been revived by the discovery that hypoxia-inducible factor 1 (HIF1) reprogrammes pyruvate oxidation to lactic acid conversion; lactic acid is the end product of fermentative glycolysis. The most aggressive and invasive cancers, which are often hypoxic, rely on exacerbated glycolysis to meet the increased demand for ATP and biosynthetic precursors and also rely on robust pH-regulating systems to combat the excessive generation of lactic and carbonic acids. In this Review, we present the key pH-regulating systems and synthesize recent advances in strategies that combine the disruption of pH control with bioenergetic mechanisms. We discuss the possibility of exploiting, in rapidly growing tumours, acute cell death by 'metabolic catastrophe'.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
炭酸脱水酵素 ウシ赤血球由来, lyophilized powder, ≥2,000 W-A units/mg protein
Sigma-Aldrich
炭酸アンヒドラーゼ ウシ赤血球由来, ≥95% (SDS-PAGE), specific activity ≥3,500 W-A units/mg protein, lyophilized powder
Sigma-Aldrich
炭酸脱水酵素 ウシ赤血球由来, BioReagent, suitable for GFC marker
Sigma-Aldrich
炭酸 アンヒドラーゼ アイソザイムII ウシ赤血球由来, lyophilized powder, ≥3,000 W-A units/mg protein
Sigma-Aldrich
炭酸脱水酵素 ウシ赤血球由来, For use as a marker in SDS-PAGE
Sigma-Aldrich
炭酸 アンヒドラーゼ I ヒト赤血球由来
Sigma-Aldrich
炭酸脱水酵素アイソザイムII ヒト, ≥80%, powder, ≥3,000 W-A units/mg protein
Sigma-Aldrich
炭酸脱水酵素 ウシ赤血球由来, non-denaturing PAGE marker
Supelco
炭酸 アンヒドラーゼ I ヒト赤血球由来, Isoelectric focusing marker, pI 6.6
Sigma-Aldrich
炭酸 アンヒドラーゼ アイソザイムII ウシ赤血球由来, Isoelectric focusing marker, pI 5.4
Sigma-Aldrich
炭酸 アンヒドラーゼ アイソザイムII ウシ赤血球由来, lyophilized powder, ≥2,000 W-A units/mg protein